oxyTOCIN 20 units added to Lactated Ringer's 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6038-1.
Published May 31, 2023 · Recall initiated: April 28, 2023
Summary
FDA records drug Class II recall D-0706-2023, published May 31, 2023 and initiated April 28, 2023. Recalling firm: Central Admixture Pharmacy Services, Inc.; Status: Terminated; Reported quantity: 14362 bags; Lot: Lot # 37-889158, 37-889187, 37-889189, Exp 04/28/2023; 37-889494, 37-889507, 37-889522, 37-889525, 37-889527, 37-889608, Exp 04/29/2023; 37-889906, 37-889912, 37-889913, Exp 04/30/2023; 37-890110, 37-890121, Exp 05/03/2023; 37-891160, 37-891162, 37-891186, 37-891188, 37-891199, 37-891211, Exp 05/06/2023; 37-891564, 37-891565, 37-891567, 37-891569, 37-891570, Exp 05/07/2023; 37-892591, Exp 05/12/2023; 37-892893, 37-892897, 37-892900, 37-892902, 37-892903, 37-892904, 37-892909, 37-892910, Exp 05/13/2023; 37-894715, 37-894720, 37-894749, 37-894754, 37-894762, 37-894763, 37-894765, Exp 05/20/2023; 37-894991, 37-894992, 37-894993, Exp 05/21/2023; 37-896187, 37-896188, 37-896190, 37-896191, 37-896199, 05/26/2023; 37-896521, 37-896522, 37-896523, Exp 05/27/2023; 37-896883, 37-896884, Exp 05/28/2023; 37-900067, 37-900068, Exp 06/10/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Distributor
- Nationwide in the USA.
- Lot
- Lot # 37-889158, 37-889187, 37-889189, Exp 04/28/2023; 37-889494, 37-889507, 37-889522, 37-889525, 37-889527, 37-889608, Exp 04/29/2023; 37-889906, 37-889912, 37-889913, Exp 04/30/2023; 37-890110, 37-890121, Exp 05/03/2023; 37-891160, 37-891162, 37-891186, 37-891188, 37-891199, 37-891211, Exp 05/06/2023; 37-891564, 37-891565, 37-891567, 37-891569, 37-891570, Exp 05/07/2023; 37-892591, Exp 05/12/2023; 37-892893, 37-892897, 37-892900, 37-892902, 37-892903, 37-892904, 37-892909, 37-892910, Exp 05/13/2023; 37-894715, 37-894720, 37-894749, 37-894754, 37-894762, 37-894763, 37-894765, Exp 05/20/2023; 37-894991, 37-894992, 37-894993, Exp 05/21/2023; 37-896187, 37-896188, 37-896190, 37-896191, 37-896199, 05/26/2023; 37-896521, 37-896522, 37-896523, Exp 05/27/2023; 37-896883, 37-896884, Exp 05/28/2023; 37-900067, 37-900068, Exp 06/10/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATotal Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx#July 1, 2026
- FDAPHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central AdmixtureMarch 19, 2025
- FDANeonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with HEPARIN, IV Bag, total volume =September 6, 2023
- FDAEPINEPHrine added to dextrose 5%, 4mg/250ml (16 mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services,September 6, 2023
- FDAoxyTOCIN 15 units added to Lactated Ringer's 250 mL per bag, Rx only, Central Admixture Pharmacy Services,May 31, 2023
- FDAoxyTOCIN 30 units added to Lactated Ringer's 500 mL per bag, Rx only, Central Admixture Pharmacy Services,May 31, 2023
Questions about this recall
Was oxyTOCIN 20 units added to Lactated Ringer's 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6038-1. recalled?
Yes. FDA published recall D-0706-2023 on May 31, 2023. Reported hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail